The company had a net profit of Rs 44.61 crore for the same period in the previous fiscal, JB Chemicals & Pharmaceuticals said in a filing to the Bombay Stock Exchange (BSE).
As the company sold its Russia-CIS OTC business to Cilag GmbH International, a subsidiary of US-based Johnson and Johnson for Rs 754.53 crore, the results of the current quarter are not comparable with the same period previous fiscal.
399
450
3100
4213
3071
4913
5447
8010
199
799
3549
4999
119
180
169
220
399
450
1682
3028
3355
4059
495
795